STAT Brand Studio (@statbrandstudio) header
STAT Brand Studio (@statbrandstudio) profile picture

Our award-winning team creates custom content that inspires, engages, and informs the STAT News audience in medicine, health care, and the life sciences.

Joined April 2019
Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)Photo by STAT Brand Studio (@statbrandstudio)
What can differences in traffic fatalities tell us about road safety? From Boston to Memphis, retrospective data reveal wide variation across U.S. cities and between daytime and nighttime driving. Trent Victor, Ph.D., senior director of safety science and management at @Waymo, discusses how studying these patterns can help researchers better understand road safety. Read more about Waymo's research here: waymo.com/blog/2026/07/time-…
14
The future of health care is often discussed in terms of new technologies. For patients managing complex chronic conditions, connecting the care they already receive is just as pressing. Misha Palecek, chief transformation officer at @DaVita, joined STAT Brand Studio’s Terzel Ron Vasquez in the STAT Summit multimedia lounge to explore both. Their conversation covered lessons from kidney care, the persistence of fragmented care, and where AI and other investments could make a practical difference. Read more: lnkd.in/etXh6cnJ
17
For Monia Vial, Pharm D., president of EMD Serono, Inc. and head of North America, the STAT Brand Studio multimedia lounge offered space to discuss leadership and the experiences behind it. Speaking with STAT Brand Studio’s Britt Whitmore, Vial explored what drew her to the company and the balance between building on an established business and bringing innovation to serve the needs of patients and their families.
19
Health care’s fragmented ecosystem presents a challenge for AI: how can it address the needs of individual physicians and patients while working at scale across hundreds of complex systems? A new generation of AI agents is connecting stakeholders, supporting physicians, and operating across disconnected environments — shaping the future of health care and bridging care gaps. @impiricus CEO and co-founder @Osama_Hashmi speaks with Jesse McQuarters in the STAT Brand Studio multimedia lounge at STAT Summit 2026.
15
Cell and gene therapies are moving beyond cancer. From CAR-T in autoimmune disease to pioneering in utero gene therapy, the field is entering a new era. Explore the science, regulation, clinical trials, and challenges shaping what's next. Download the latest STAT e-book: shorturl.at/JqlJ7
18
Bringing a new therapy from discovery to patient care can take a decade or more, even when the science goes according to plan. At BIO 2026, industry leaders discussed why so many delays happen between stages of development and how AI, global collaboration, and stronger partnerships could help keep programs moving. Read more: statnews.com/sponsor/2026/09…
29
Biotech has spent decades accelerating discovery. The next challenge? Making sure those breakthroughs reach patients. At @STAT's Breakthrough West 2026, leaders from @Genentech discussed the gap between innovation and access — and how technology, data, and AI are helping bridge it. Read more: statnews.com/sponsor/2026/08…
1
29
Many IBD patients eventually lose response to therapies that once worked. Johnson & Johnson's Esi Lamousé-Smith discusses how dual-pathway, co-antibody therapies could provide another treatment option while advancing more patient-centered care. Read more: statnews.com/sponsor/2026/08…
30
Biology is evolving at a remarkable pace, and biomanufacturing must evolve with it. Daniel Bracewell, Professor at University College London, joined @STAT Brand Studio at the 2026 @Danaher Summit in London to discuss why staying current requires more than simply embracing AI — it also means keeping pace with the rapid evolution of biology itself. Read more: tinyurl.com/3kmcc6sh
33
What is government's role in biomanufacturing innovation? Steve Bates, OBE, Executive Chair of the U.K. Office for Life Sciences, joined @STAT Brand Studio moderator Jesse McQuarters at the 2026 @Danaher Summit in London to discuss why regulation is essential to bringing new bioprocessing technologies into health care. Bates explains why timely, appropriate oversight helps ensure innovation reaches patients safely and quickly. Read more: fb.watch/IQOxqpUJNF/
42
You can't scale biologics without the people to make them. At the 2026 Danaher Summit, Steve Bates, Dan Bracewell, and Alistair Stuart discussed why workforce development is becoming an essential piece of strategic infrastructure. Four takeaways from the conversation, moderated by STAT Brand Studio and informed by new research from @Cytiva: statnews.com/sponsor/2026/08… #Bioprocessing #Biopharma #Danaher #Cytiva
41
One study changed the conversation around HIV. Fifteen years after HIV Prevention Trials Network (HPTN) 052, Jared Baeten of @Gilead reflects on how U=U transformed care, challenged stigma, and helped reshape the global HIV response, and why the work to end the epidemic is far from over. Listen to the conversation here: shorturl.at/LsgOQ
42
AI is transforming health care, but much of the data structure powering today's models were built for a different era. Leslie Oley Wilberforce, CEO of @evidation, explains why the future of AI depends on building a richer, more continuous picture of patient health beyond the clinic. Read more: statnews.com/sponsor/2026/07…
23
Driven by a deep heritage in science, @GileadSciences and @KitePharma are establishing their leadership in oncology. Dietmar Berger, Chief Medical Officer of Gilead, shares his perspective on how advances in science, technology and collaboration are shaping their vision for the future of cancer care: statnews.com/sponsor/2026/07…
3
1
4
781
How are targeted therapies changing cancer care? At ASCO 2026, @ChumiKhurana of Jazz Pharmaceuticals discusses precision oncology, advances in neuro-oncology, and the ongoing search for new options in rare cancers. Read more: statnews.com/sponsor/2026/07…
25
Clinical research is entering a new era of speed and efficiency. At Breakthrough West, @Medidata CEO Anthony Costello discussed how AI, wearable devices, and real-world data are accelerating research and bringing therapies to patients faster. statnews.com/sponsor/2026/07…
2
2
91